Does CC-4047 Cause Plasma cell myeloma? 42 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 42 reports of Plasma cell myeloma have been filed in association with CC-4047. This represents 36.8% of all adverse event reports for CC-4047.
42
Reports of Plasma cell myeloma with CC-4047
36.8%
of all CC-4047 reports
35
Deaths
9
Hospitalizations
How Dangerous Is Plasma cell myeloma From CC-4047?
Of the 42 reports, 35 (83.3%) resulted in death, 9 (21.4%) required hospitalization, and 4 (9.5%) were considered life-threatening.
Is Plasma cell myeloma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CC-4047. However, 42 reports have been filed with the FAERS database.
What Other Side Effects Does CC-4047 Cause?
Death (13)
Neutropenia (10)
Thrombocytopenia (10)
Anaemia (8)
Pneumonia (8)
Leukopenia (6)
Febrile neutropenia (5)
Neutrophil count decreased (5)
Pancytopenia (5)
Renal failure acute (5)
What Other Drugs Cause Plasma cell myeloma?
LENALIDOMIDE (14,191)
DEXAMETHASONE (9,207)
POMALIDOMIDE (7,023)
BORTEZOMIB (6,683)
IXAZOMIB (3,249)
DARATUMUMAB (2,980)
CARFILZOMIB (2,238)
CYCLOPHOSPHAMIDE (2,058)
THALIDOMIDE (1,652)
SELINEXOR (1,046)
Which CC-4047 Alternatives Have Lower Plasma cell myeloma Risk?
CC-4047 vs CEDAZURIDINE\DECITABINE
CC-4047 vs CEDIRANIB
CC-4047 vs CEFACLOR
CC-4047 vs CEFADROXIL
CC-4047 vs CEFAZOLIN